ADHD severity

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Greater baseline ADHD severity predicted greater reduction in ADHD symptoms and greater odds of achieving a 50% reduction in substance use, regardless of medication assignment.

Effect: improvement; regression coefficient = 0.64 (ADHD change); OR=1.06 (SUD responder); CI: 95% CI: 1.01 to 1.11 (SUD responder)

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0

Childhood ADHD severity of role impairment, defined as impairment across all four domains (home, school, social, personal relationships), significantly predicted adult persistence of ADHD after contro

Effect: decline; OR 2.0